|
RAB22A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.198300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.641800E-04 |
| Normal-vs-Stage2 |
3.608200E-01 |
| Normal-vs-Stage3 |
3.781300E-04 |
| Normal-vs-Stage4 |
5.97569999999381E-05 |
| Stage1-vs-Stage2 |
3.525900E-02 |
| Stage1-vs-Stage3 |
4.805200E-01 |
| Stage1-vs-Stage4 |
8.601600E-02 |
| Stage2-vs-Stage3 |
2.377800E-02 |
| Stage2-vs-Stage4 |
6.861600E-03 |
| Stage3-vs-Stage4 |
3.583600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.041590E-04 |
| Normal-vs-AfricanAmerican |
1.430220E-01 |
| Normal-vs-Asian |
3.059600E-03 |
| Caucasian-vs-AfricanAmerican |
2.979600E-01 |
| Caucasian-vs-Asian |
8.211800E-01 |
| AfricanAmerican-vs-Asian |
3.717800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.324900E-03 |
| Normal-vs-Female |
1.590390E-04 |
| Male-vs-Female |
5.676200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.876990E-03 |
| Normal-vs-Age(41-60Yrs) |
1.360510E-04 |
| Normal-vs-Age(61-80Yrs) |
3.680800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.204590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.271000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.502600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.596200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.371400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.398400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.796600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.151800E-01 |
| Classical-VS-Follicular |
9.740400E-01 |
| Classical-VS-Other |
8.008800E-01 |
| Classical-VS-Normal |
8.380300E-04 |
| Tall-VS-Follicular |
6.116600E-01 |
| Tall-VS-Other |
6.580800E-01 |
| Tall-VS-Normal |
9.703300E-03 |
| Follicular-VS-Other |
7.332800E-01 |
| Follicular-VS-Normal |
1.100350E-02 |
| Other-VS-Normal |
4.290200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.372500E-04 |
| Normal-vs-N1 |
8.40440000000608E-05 |
| N0-vs-N1 |
1.122360E-01 |
|
|
